[
    [
        {
            "time": "",
            "original_text": "传药明巨诺明日聆讯：药明康德持股14% 中期亏损1.58亿 亏损",
            "features": {
                "keywords": [
                    "药明巨诺",
                    "聆讯",
                    "药明康德",
                    "持股",
                    "中期亏损"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "传药明巨诺明日聆讯：药明康德持股14% 中期亏损1.58亿 亏损",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药行业2020年四季度投资策略：业绩验证化解估值压力",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "业绩验证",
                    "估值压力"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2020年四季度投资策略：业绩验证化解估值压力",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业2020三季度业绩前瞻：板块分化明显 医疗服务等板块有序复苏",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩前瞻",
                    "板块分化",
                    "医疗服务",
                    "复苏"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2020三季度业绩前瞻：板块分化明显 医疗服务等板块有序复苏",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "晨会聚焦201014重点关注丽人丽妆、交运行业、纺织服装、证券行业、有色行业、汽车行业",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "丽人丽妆",
                    "交运行业",
                    "纺织服装",
                    "证券行业",
                    "有色行业",
                    "汽车行业"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "交运",
                    "纺织服装",
                    "证券",
                    "有色",
                    "汽车"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会聚焦201014重点关注丽人丽妆、交运行业、纺织服装、证券行业、有色行业、汽车行业",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "明晚8点！浅谈临床前动物药效模型与临床试验成败的相关性及转化科学 | 体内药理药效系列（三）",
            "features": {
                "keywords": [
                    "临床前",
                    "动物药效模型",
                    "临床试验",
                    "转化科学"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "明晚8点！浅谈临床前动物药效模型与临床试验成败的相关性及转化科学 | 体内药理药效系列（三）",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "先声药业昨日启动招股：能否复制药明康德式奇迹？",
            "features": {
                "keywords": [
                    "先声药业",
                    "招股",
                    "药明康德",
                    "奇迹"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "先声药业昨日启动招股：能否复制药明康德式奇迹？",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "想做龙头？背靠中国人寿和健康大基金的卫宁科技引入京东健康、药明康德 但竞争对手正虎视眈眈",
            "features": {
                "keywords": [
                    "卫宁科技",
                    "中国人寿",
                    "健康大基金",
                    "京东健康",
                    "药明康德",
                    "竞争对手"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "想做龙头？背靠中国人寿和健康大基金的卫宁科技引入京东健康、药明康德 但竞争对手正虎视眈眈",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "定增新规下首批项目迎解禁，收益率落差明显",
            "features": {
                "keywords": [
                    "定增新规",
                    "解禁",
                    "收益率",
                    "落差"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "定增新规下首批项目迎解禁，收益率落差明显",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]